SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹887 Cr | ₹783 Cr | ₹709 Cr | ₹522 Cr | ₹520 Cr |
What is the latest Revenue of SMS PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹887 Cr |
| Mar2025 | ₹783 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹522 Cr |
| Mar2022 | ₹520 Cr |
How is Revenue of SMS PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹887 Cr | 13.30 | |
| Mar2025 | ₹783 Cr | 10.36 | |
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | - | |
Compare Revenue of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹4,370.6 Cr | 13.5% | 30.7% | 52% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 13.5% |
30.7% |
52% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses